| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.400 | None | 0.950 | 2 | 0 | 1995 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2013 | ||||||||
|
ATP binding cassette subfamily C member 4 | 0.536 | 0.769 | 1.1E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2017 | ||||||||
|
ATP binding cassette subfamily C member 5 | 0.606 | 0.654 | 4.2E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 1999 | 2010 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.400 | None | 0.957 | 1 | 0 | 2003 | 2020 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
AF4/FMR2 family member 3 | 0.623 | 0.692 | 1.00 |
|
disease | 0.460 | None | 1.000 | 2 | 0 | 2009 | 2016 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.470 | None | 1.000 | 1 | 0 | 2002 | 2014 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.929 | 1 | 0 | 2008 | 2020 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 1995 | 2017 | ||||||||
|
ankyrin repeat domain 55 | 0.650 | 0.462 | 6.8E-08 |
|
disease | 0.440 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
annexin A3 | 0.610 | 0.615 | 6.5E-12 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | 0.576 | 0.731 | 3.0E-19 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2016 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 0.705 | 0.500 | 0.89 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 1988 | 2013 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 | 1.000 | 0.115 | 1.7E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BAR/IMD domain containing adaptor protein 2 like 1 | 0.805 | 0.308 | 1.0E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BCL2 related protein A1 | 0.529 | 0.731 | 0.21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2017 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
biglycan | 0.484 | 0.808 | 0.45 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.460 | None | 1.000 | 2 | 0 | 2009 | 2016 |